Drug Profile
Research programme: monoclonal antibodies - Cancer Research Center of Lyon/iDD biotech
Alternative Names: iDD 005Latest Information Update: 28 Apr 2021
Price :
$50
*
At a glance
- Originator Cancer Research Centre of Lyon
- Developer Cancer Research Centre of Lyon; iDD Biotech
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Surface antigen modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer